Donald Hill joined the FNIH in August 2017 as the Chief Financial Officer of the Foundation. He brings more than 30 years of financial experience with for-profit and not-for-profit organizations. His experience includes CFO roles with Project HOPE, a global health education and humanitarian organization, and Metabolex (CymaBay Therapeutics), a biopharmaceutical company focused on the discovery and development of new medicines for the treatment of metabolic diseases. His career also includes more than 20 years at Merck & Co., in various Finance and Corporate Development roles. Additionally, he worked with Amneal Enterprises and its associated portfolio companies.
He received his M.S. in Finance and Applied Economics from the Sloan School of Management at the Massachusetts Institute of Technology and his B.A. in Political Economy from the University of California, Berkeley. He also holds the Chartered Financial Analyst (CFA) designation.
Current role